![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Company type
Focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted canceFunding rounds
Series C
( )
| Investor | Profile | Country | |
|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Gilde Investment Management | ||
|
|
Phase4 Ventures Ltd | ||
|
Wellcome Trust |
| Investor | Profile | Country | |
|---|---|---|---|
|
Essex Woodlands Health Ventures Inc | ||
|
ETV Capital SA (European Technology Ventures) | ||
|
Hercules Technology Growth Capital Inc | Specialised finance company providing debt and equity growth capital to technology-related companies at all stages of development. | |
|
University of Cambridge |
Investment activity status
Active investor